In Vitro Diagnostics Market Research Reports & Industry Analysis

The publications below represent comprehensive market research on components of the global market for in vitro diagnostics. Reports, published by several different research companies, address financial analyses of major companies, overview analyses of the global market, and specific analyses on individual countries or individual and more specific segments of the market, such as cell analysis.
...Show More ...Show Less


In Vitro Diagnostics Industry Research & Market Reports

  • Global Human Fibrinogen Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

    ... is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications ... Read More

  • Global Mononucleosis Diagnostic Databank Market Report

    ... 2031. Complete Blood Count Test segment is expected to be the highest contributor to this market, with $1,138.6 Million in 2022, and is anticipated to reach $1,210.1 Million by 2031, registering a CAGR of 0.71%. ... Read More

  • Global Microtomes Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

    ... slices of material, known as sections. Important in science, microtomes are used in microscopy, allowing for the preparation of samples for observation under transmitted light or electron radiation. Microtomes use steel, glass, or diamond blades ... Read More

  • Global Legionella Testing Databank Market Report

    ... 2031. Water Testing segment is expected to be the highest contributor to this market, with $222.7 Million in 2022, and is anticipated to reach $394.2 Million by 2031, registering a CAGR of 6.60%. IVD Testing ... Read More

  • Global Cancer Diagnostics Databank Market Report

    ... 2031. Consumables segment is expected to be the highest contributor to this market, with $167,321.8 Million in 2022, and is anticipated to reach $261,623.1 Million by 2031, registering a CAGR of 5.13%. Instruments segment is ... Read More

  • Global Single-cell Analysis Databank Market Report

    ... 2031. Consumables segment is expected to be the highest contributor to this market, with $2,135.0 Million in 2022, and is anticipated to reach $8,071.3 Million by 2031, registering a CAGR of 16.01%. Instruments segment is ... Read More

  • Global Metabolic Testing Databank Market Report

    ... 2029. Body Composition Analyzers segment is expected to be the highest contributor to this market, with $256.7 Million in 2020, and is anticipated to reach $394.6 Million by 2029, registering a CAGR of 4.94%. Body ... Read More

  • Global Immunoassay Instruments Databank Market Report

    ... 2031. Consumables & Accessories segment is expected to be the highest contributor to this market, with $11,524.5 Million in 2022, and is anticipated to reach $16,252.3 Million by 2031, registering a CAGR of 3.93%. Chemiluminescence ... Read More

  • Global Hematology Diagnostics Databank Market Report

    ... 2031. Consumables segment is expected to be the highest contributor to this market, with $4,765.6 Million in 2022, and is anticipated to reach $7,132.2 Million by 2031, registering a CAGR of 4.62%. Instrument segment is ... Read More

  • Global Hepatitis Diagnostic Test Databank Market Report

    ... 2023 to 2031. Blood tests segment is expected to be the highest contributor to this market, with $2,457.2 Million in 2022, and is anticipated to reach $3,721.6 Million by 2031, registering a CAGR of 4.76%. ... Read More

  • Global Nucleic Acid Labeling Databank Market Report

    ... 2023 to 2031. Reagents segment is expected to be the highest contributor to this market, with $830.9 Million in 2022, and is anticipated to reach $1,453.3 Million by 2031, registering a CAGR of 6.46%. Instruments ... Read More

  • Global Cell Sorting Databank Market Report

    ... 2031. Cell Sorters segment is expected to be the highest contributor to this market, with $205.4 Million in 2022, and is anticipated to reach $416.4 Million by 2031, registering a CAGR of 8.22%. Services segment ... Read More

  • Microtomes Industry Research Report 2024

    ... Important in science, microtomes are used in microscopy, allowing for the preparation of samples for observation under transmitted light or electron radiation. Microtomes use steel, glass, or diamond blades depending upon the specimen being sliced ... Read More

  • Global Rabies Diagnostics Databank Market Report

    ... 2031. Immunohistochemical Test segment is expected to be the highest contributor to this market, with $83,817.0 Million in 2022, and is anticipated to reach $105,993.9 Million by 2031, registering a CAGR of 2.68%. Histologic Examination ... Read More

  • Global Clinical Diagnostics Databank Market Report

    ... 2031. Instruments segment is expected to be the highest contributor to this market, with $57.8 Million in 2022, and is anticipated to reach $59.0 Million by 2031, registering a CAGR of 0.27%. Reagents segment is ... Read More

  • Global Non-invasive Prenatal Diagnostics Databank Market Report

    ... 2023 to 2031. 13-24 Weeks segment is expected to be the highest contributor to this market, with $2,221.5 Million in 2022, and is anticipated to reach $4,609.1 Million by 2031, registering a CAGR of 8.50%. ... Read More

  • Global Influenza Diagnostics Databank Market Report

    ... 2029. RT-PCR segment is expected to be the highest contributor to this market, with $339.2 Million in 2020, and is anticipated to reach $425.1 Million by 2029, registering a CAGR of 2.58%. Cell Culture segment ... Read More

  • Global Sepsis Diagnostics Databank Market Report

    ... from 2021 to 2029. Instruments segment is expected to be the highest contributor to this market, with $422.6 Million in 2020, and is anticipated to reach $703.1 Million by 2029, registering a CAGR of 5.86%. Read More

  • Global Protein Binding Assays Databank Market Report

    ... 2023 to 2031. Pharmaceutical & biotechnology companies segment is expected to be the highest contributor to this market, with $161.0 Million in 2022, and is anticipated to reach $266.7 Million by 2031, registering a CAGR ... Read More

  • Global Microfluidics Prototype Databank Market Report

    ... 2031. Polymer segment is expected to be the highest contributor to this market, with $10,792.4 Million in 2022, and is anticipated to reach $34,467.0 Million by 2031, registering a CAGR of 13.85%. Silicone segment is ... Read More

  • Global Cellular Health Screening Databank Market Report

    ... 2021 to 2029. Single Test Panels segment is expected to be the highest contributor to this market, with $2,107.5 Million in 2020, and is anticipated to reach $4,244.9 Million by 2029, registering a CAGR of ... Read More

  • Global Microtomes Market Size, Manufacturers, Opportunities and Forecast to 2030

    ... known as sections. Important in science, microtomes are used in microscopy, allowing for the preparation of samples for observation under transmitted light or electron radiation. Microtomes use steel, glass, or diamond blades depending upon the ... Read More

  • Global Microtomes Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030

    ... extremely thin slices of material, known as sections. Important in science, microtomes are used in microscopy, allowing for the preparation of samples for observation under transmitted light or electron radiation. Microtomes use steel, glass, or ... Read More

  • Human Fibrinogen Industry Research Report 2024

    ... is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products ... Read More

  • Global Human Fibrinogen Market Size, Manufacturers, Opportunities and Forecast to 2030

    ... for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes ... Read More

Cookie Settings